CLINICAL_TRIALS
research
· 2024-10-10
Clinical Trial Update: Efficacy of Venetoclax Combined with Intensive Chemotherapy in Different Subgroups of AML [Phase 2]
Summary
A Phase 2 trial assessing venetoclax with intensive chemotherapy in different subgroups of acute myeloid leukemia is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: AML (Acute Myelogenous Leukemia) | Phase 2 | Status: RECRUITING